Herbal Actives Cascara Sagrada 100 mg/25-30% Hydroxyanthracene Derivatives

Name: Herbal Actives Cascara Sagrada 100 mg/25-30% Hydroxyanthracene Derivatives
Brand: Nature's Plus

BrandNature's Plus→Botanical Capsule 6 ingredients 2 caution DSLD #49349

Net contents: 60 Vegetarian Capsule(s)

Target: Adults and Children 4 years and above

DSLD entry: 2015-08-25

2 Ingredients (6)

IngredientGroupSafety

Cascara SagradaCascara SagradaUse with Caution

Microcrystalline CelluloseCellulose—

Vegetable CelluloseCellulose—

SilicaSiliconGenerally Safe

Magnesium StearateMagnesiumUse with Caution

purified WaterWater—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Cascara Sagrada 🇪🇺 — Hydroxyanthracene derivatives under assessment.

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Cascara Sagrada — Use with Caution

⚠ Stimulant laxative — same chronic abuse risk as senna

⚠ Electrolyte imbalance

Silicon — Generally Safe

⚠ Very low toxicity

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID49349

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2015-08-25

6 More from Nature's Plus

View Nature's Plus Safety Scorecard → 26 products

Advanced Therapeutics Glucofit Rx-Blood Sugar Advanced Therapeutics Huperzine Rx-Brain Advanced Therapeutics Ribose Rx-Energy Alfalfa 8 1/2 Grain Antioxidant Formula Ultra Activin Apple Pectin 500 mg

7 Cite this page

Vancouver

Pkhakadze G. Herbal Actives Cascara Sagrada 100 mg/25-30% Hydroxyanthracene Derivatives — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/herbal-actives-cascara-sagrada-100-mg-25-30-hydroxyanthracene-derivatives-49349/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG